Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
Clinical trial NCT02910050 · UNKNOWN
Trial details
- NCT number
- NCT02910050
- Sponsor
- Xu fei
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.